Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
19.00
+0.69 (3.77%)
Feb 26, 2026, 3:17 PM EST - Market open
Caris Life Sciences Employees
Caris Life Sciences had 1,769 employees as of March 31, 2025. The number of employees did not change since the number was last reported on December 31, 2024.
Employees
1,769
Change
n/a
Growth
n/a
Revenue / Employee
$366,909
Profits / Employee
-$385,449
Market Cap
5.36B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 1,769 | 0 | - | - | - |
| Dec 31, 2024 | 1,769 | 1 | 0.06% | 1,769 | 0 |
| Dec 31, 2023 | 1,768 | - | - | 1,762 | 6 |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Amicus Therapeutics | 499 |
| Crinetics Pharmaceuticals | 437 |
| CRISPR Therapeutics AG | 393 |
| Immunovant | 362 |
| Structure Therapeutics | 218 |
| Apogee Therapeutics | 196 |
| Protagonist Therapeutics | 128 |
CAI News
- 9 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 9 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 9 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 9 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC